• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

BMJ Open . Nudging towards COVID-19 and influenza vaccination uptake in medically at-risk children: EPIC study protocol of randomised controlled tri

tetano

Editor, Senior Moderator
BMJ Open


. 2024 Feb 17;14(2):e076194.
doi: 10.1136/bmjopen-2023-076194. Nudging towards COVID-19 and influenza vaccination uptake in medically at-risk children: EPIC study protocol of randomised controlled trials in Australian paediatric outpatient clinics

Bing Wang[SUP] 1 2 3 [/SUP], Prabha Andraweera[SUP] 1 2 3 [/SUP], Margaret Danchin[SUP] 4 5 6 [/SUP], Christopher C Blyth[SUP] 7 8 9 [/SUP], Ivo Vlaev[SUP] 10 [/SUP], Jason Ong[SUP] 11 [/SUP], Jodie M Dodd[SUP] 2 3 12 [/SUP], Jennifer Couper[SUP] 2 3 13 [/SUP], Thomas R Sullivan[SUP] 14 15 [/SUP], Jonathan Karnon[SUP] 16 [/SUP], Nicola Spurrier[SUP] 17 18 [/SUP], Michael Cusack[SUP] 17 [/SUP], Dylan Mordaunt[SUP] 18 [/SUP], Dimi Simatos[SUP] 19 [/SUP], Gustaaf Dekker[SUP] 2 3 20 [/SUP], Samantha Carlson[SUP] 7 [/SUP], Jane Tuckerman[SUP] 4 6 [/SUP], Nicholas Wood[SUP] 21 22 [/SUP], Lisa J Whop[SUP] 23 [/SUP], Helen Marshall[SUP] 24 2 3 [/SUP]



Affiliations
Free article Abstract

Introduction: Children with chronic medical diseases are at an unacceptable risk of hospitalisation and death from influenza and SARS-CoV-2 infections. Over the past two decades, behavioural scientists have learnt how to design non-coercive 'nudge' interventions to encourage positive health behaviours. Our study aims to evaluate the impact of multicomponent nudge interventions on the uptake of COVID-19 and influenza vaccines in medically at-risk children.
Methods and analyses: Two separate randomised controlled trials (RCTs), each with 1038 children, will enrol a total of approximately 2076 children with chronic medical conditions who are attending tertiary hospitals in South Australia, Western Australia and Victoria. Participants will be randomly assigned (1:1) to the standard care or intervention group. The nudge intervention in each RCT will consist of three text message reminders with four behavioural nudges including (1) social norm messages, (2) different messengers through links to short educational videos from a paediatrician, medically at-risk child and parent and nurse, (3) a pledge to have their child or themselves vaccinated and (4) information salience through links to the current guidelines and vaccine safety information. The primary outcome is the proportion of medically at-risk children who receive at least one dose of vaccine within 3 months of randomisation. Logistic regression analysis will be performed to determine the effect of the intervention on the probability of vaccination uptake.
Ethics and dissemination: The protocol and study documents have been reviewed and approved by the Women's and Children's Health Network Human Research Ethics Committee (HREC/22/WCHN/2022/00082). The results will be published via peer-reviewed journals and presented at scientific meetings and public forums.
Trial registration number: NCT05613751.

Keywords: COVID-19; INFECTIOUS DISEASES; Primary Prevention; Public health.

 
Back
Top Bottom